Tivozanib Withdrawn Phase 1 / 2 Trials for EGFR Unknown or Wild-type / Lung Cancer Non-Small Cell Cancer (NSCLC) / Stage IV Disease Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs